Back

Contemporary description of cardiac manifestations in ATTR amyloidosis: results from the multi-country OverTTuRe study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: The different faces of cardiac amyloidosis Neurologic Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Lisa Anderson

St George's University Hospital NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Sustained paradoxical vasodilation and blood pressure lowering in response to sympathetic stimulation as markers of disease severity and poor survival in primary AL amyloidosis.
Doctor K. Stamatelopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Changes in the diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM): a comparison of tests ordered and test Intervals in 2020 Q4 and 2023 Q4
Mr P. Collins (London, GB)
Abstract Slides Video
Presentation thumbnail
Frailty and associated outcomes in patients with transthyretin cardiac amyloidosis
Doctor C. Fumagalli (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac transthyretin amyloidosis in patients with conduction system disease
Doctor J. Pudich (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
ATTR cardiac amyloidosis after lumbar spinal stenosis- a prospective cohort study
Doctor P. Eldhagen (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
The different faces of cardiac amyloidosis

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Treatment patterns and clinical outcomes following diagnosis in patients with ATTR Amyloidosis - Results from the OverTTuRe Study
thumbnail
Congress Presentation
Early clinical manifestations and time-to-diagnosis in patients with ATTR amyloidosis with mixed phenotype - results from the OverTTuRe study
thumbnail
Congress Presentation
Time from first recorded clinical manifestation to diagnosis of transthyretin amyloid cardiomyopathy: a retrospective cohort study using US claims data

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources